Skip to main content
DWTX
NASDAQ Life Sciences

Positive Halneuron® Phase 2b Interim Data Boosts Dogwood Therapeutics, Cash Runway Extended

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.11
Mkt Cap
$107.212M
52W Low
$2.6
52W High
$9.5
52W Position info
20% above low
Off High info
67% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

DWTX sits 20% above its 52-week low of $2.6.

Summary

Dogwood Therapeutics reported its fourth quarter and full year 2025 financial results, alongside significant operational updates. The company announced positive interim data from its Halneuron® Phase 2b trial, indicating the drug is separating from placebo, with top-line results anticipated in Q3 2026. This clinical progress is a crucial de-risking event for their lead product candidate. Additionally, Dogwood completed a financing of up to $26.9 million in January 2026, with $12.5 million already received, which is expected to fund operations through the Phase 2b data readout and into the fourth quarter of 2026. While the full-year net loss widened to $35.5 million, the market is likely to prioritize the positive clinical development and the secured cash runway for this development-stage biotech. Investors will now focus on the full Phase 2b results and further financing updates.

At the time of this announcement, DWTX was trading at $3.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $107.2M. The 52-week trading range was $2.60 to $9.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

DWTX - Latest Insights

DWTX
Nov 06, 2026, 9:18 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $1.32 info
Change: +$0.220 (+20%) info
Market Cap: $48.932M info
DWTX
Nov 05, 2026, 8:30 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $1.32 info
Change: +$0.220 (+20%) info
Market Cap: $48.932M info
DWTX
Oct 19, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.36
Real-time Price: $1.32 info
Change: -$0.040 (-3%) info
Market Cap: $48.932M info
DWTX
Oct 19, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $1.32 info
Change: +$0.070 (+6%) info
Market Cap: $48.932M info
DWTX
Sep 14, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.04
Real-time Price: $1.32 info
Change: -$0.720 (-35%) info
Market Cap: $48.932M info